nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP2C19—Memantine—Alzheimer's disease	0.177	0.28	CbGbCtD
Etravirine—CYP2C9—Donepezil—Alzheimer's disease	0.17	0.268	CbGbCtD
Etravirine—CYP3A4—Rivastigmine—Alzheimer's disease	0.124	0.195	CbGbCtD
Etravirine—CYP3A4—Donepezil—Alzheimer's disease	0.0989	0.156	CbGbCtD
Etravirine—CYP3A4—Galantamine—Alzheimer's disease	0.0637	0.101	CbGbCtD
Etravirine—Pancreatitis—Donepezil—Alzheimer's disease	0.00124	0.00402	CcSEcCtD
Etravirine—Angina pectoris—Donepezil—Alzheimer's disease	0.00123	0.00399	CcSEcCtD
Etravirine—Eye disorder—Galantamine—Alzheimer's disease	0.00122	0.00396	CcSEcCtD
Etravirine—Dry skin—Memantine—Alzheimer's disease	0.00122	0.00395	CcSEcCtD
Etravirine—Cardiac disorder—Galantamine—Alzheimer's disease	0.00121	0.00393	CcSEcCtD
Etravirine—Dry skin—Rivastigmine—Alzheimer's disease	0.00119	0.00386	CcSEcCtD
Etravirine—Angiopathy—Galantamine—Alzheimer's disease	0.00118	0.00384	CcSEcCtD
Etravirine—Immune system disorder—Galantamine—Alzheimer's disease	0.00118	0.00382	CcSEcCtD
Etravirine—Gastritis—Memantine—Alzheimer's disease	0.00117	0.00381	CcSEcCtD
Etravirine—Breast disorder—Rivastigmine—Alzheimer's disease	0.00117	0.00381	CcSEcCtD
Etravirine—Gastritis—Rivastigmine—Alzheimer's disease	0.00115	0.00373	CcSEcCtD
Etravirine—Mental disorder—Galantamine—Alzheimer's disease	0.00114	0.00371	CcSEcCtD
Etravirine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00114	0.0037	CcSEcCtD
Etravirine—Malnutrition—Galantamine—Alzheimer's disease	0.00114	0.00368	CcSEcCtD
Etravirine—Bronchospasm—Memantine—Alzheimer's disease	0.00113	0.00366	CcSEcCtD
Etravirine—Pancreatitis—Memantine—Alzheimer's disease	0.00112	0.00365	CcSEcCtD
Etravirine—Flatulence—Galantamine—Alzheimer's disease	0.00112	0.00363	CcSEcCtD
Etravirine—Angina pectoris—Memantine—Alzheimer's disease	0.00112	0.00362	CcSEcCtD
Etravirine—Tension—Galantamine—Alzheimer's disease	0.00111	0.00362	CcSEcCtD
Etravirine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00111	0.0036	CcSEcCtD
Etravirine—Renal failure—Donepezil—Alzheimer's disease	0.00111	0.00359	CcSEcCtD
Etravirine—Myocardial infarction—Donepezil—Alzheimer's disease	0.0011	0.00358	CcSEcCtD
Etravirine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.0011	0.00358	CcSEcCtD
Etravirine—Nervousness—Galantamine—Alzheimer's disease	0.0011	0.00358	CcSEcCtD
Etravirine—Pancreatitis—Rivastigmine—Alzheimer's disease	0.0011	0.00357	CcSEcCtD
Etravirine—Conjunctivitis—Donepezil—Alzheimer's disease	0.0011	0.00355	CcSEcCtD
Etravirine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00109	0.00355	CcSEcCtD
Etravirine—Vision blurred—Galantamine—Alzheimer's disease	0.00107	0.00347	CcSEcCtD
Etravirine—Tremor—Galantamine—Alzheimer's disease	0.00106	0.00345	CcSEcCtD
Etravirine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00105	0.00342	CcSEcCtD
Etravirine—Anaemia—Galantamine—Alzheimer's disease	0.00105	0.00341	CcSEcCtD
Etravirine—Hyperglycaemia—Memantine—Alzheimer's disease	0.00104	0.00336	CcSEcCtD
Etravirine—Malaise—Galantamine—Alzheimer's disease	0.00102	0.00332	CcSEcCtD
Etravirine—Vertigo—Galantamine—Alzheimer's disease	0.00102	0.00331	CcSEcCtD
Etravirine—Syncope—Galantamine—Alzheimer's disease	0.00102	0.0033	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00101	0.00329	CcSEcCtD
Etravirine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00101	0.00328	CcSEcCtD
Etravirine—Hepatitis—Donepezil—Alzheimer's disease	0.00101	0.00328	CcSEcCtD
Etravirine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00101	0.00327	CcSEcCtD
Etravirine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00101	0.00326	CcSEcCtD
Etravirine—Renal failure—Memantine—Alzheimer's disease	0.00101	0.00326	CcSEcCtD
Etravirine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.001	0.00325	CcSEcCtD
Etravirine—Myocardial infarction—Memantine—Alzheimer's disease	0.001	0.00325	CcSEcCtD
Etravirine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000999	0.00324	CcSEcCtD
Etravirine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000999	0.00324	CcSEcCtD
Etravirine—Conjunctivitis—Memantine—Alzheimer's disease	0.000994	0.00323	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000992	0.00322	CcSEcCtD
Etravirine—Urethral disorder—Donepezil—Alzheimer's disease	0.000992	0.00322	CcSEcCtD
Etravirine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000987	0.0032	CcSEcCtD
Etravirine—Convulsion—Galantamine—Alzheimer's disease	0.000984	0.00319	CcSEcCtD
Etravirine—Renal failure—Rivastigmine—Alzheimer's disease	0.000984	0.00319	CcSEcCtD
Etravirine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000981	0.00318	CcSEcCtD
Etravirine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000981	0.00318	CcSEcCtD
Etravirine—Hypertension—Galantamine—Alzheimer's disease	0.000981	0.00318	CcSEcCtD
Etravirine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000973	0.00315	CcSEcCtD
Etravirine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000968	0.00314	CcSEcCtD
Etravirine—Anxiety—Galantamine—Alzheimer's disease	0.000964	0.00313	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000961	0.00312	CcSEcCtD
Etravirine—Discomfort—Galantamine—Alzheimer's disease	0.000956	0.0031	CcSEcCtD
Etravirine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000947	0.00307	CcSEcCtD
Etravirine—Dry mouth—Galantamine—Alzheimer's disease	0.000946	0.00307	CcSEcCtD
Etravirine—Confusional state—Galantamine—Alzheimer's disease	0.000935	0.00303	CcSEcCtD
Etravirine—Hepatitis—Memantine—Alzheimer's disease	0.000918	0.00298	CcSEcCtD
Etravirine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000914	0.00296	CcSEcCtD
Etravirine—Shock—Galantamine—Alzheimer's disease	0.000912	0.00296	CcSEcCtD
Etravirine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000909	0.00295	CcSEcCtD
Etravirine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000908	0.00294	CcSEcCtD
Etravirine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000907	0.00294	CcSEcCtD
Etravirine—Connective tissue disorder—Memantine—Alzheimer's disease	0.000903	0.00293	CcSEcCtD
Etravirine—Skin disorder—Galantamine—Alzheimer's disease	0.000901	0.00292	CcSEcCtD
Etravirine—Urethral disorder—Memantine—Alzheimer's disease	0.0009	0.00292	CcSEcCtD
Etravirine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000898	0.00291	CcSEcCtD
Etravirine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000896	0.00291	CcSEcCtD
Etravirine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000894	0.0029	CcSEcCtD
Etravirine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000887	0.00288	CcSEcCtD
Etravirine—Mental disorder—Donepezil—Alzheimer's disease	0.000886	0.00287	CcSEcCtD
Etravirine—Anorexia—Galantamine—Alzheimer's disease	0.000884	0.00287	CcSEcCtD
Etravirine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000883	0.00286	CcSEcCtD
Etravirine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000881	0.00286	CcSEcCtD
Etravirine—Malnutrition—Donepezil—Alzheimer's disease	0.000881	0.00286	CcSEcCtD
Etravirine—Erythema multiforme—Memantine—Alzheimer's disease	0.000868	0.00282	CcSEcCtD
Etravirine—Flatulence—Donepezil—Alzheimer's disease	0.000868	0.00281	CcSEcCtD
Etravirine—Tension—Donepezil—Alzheimer's disease	0.000864	0.0028	CcSEcCtD
Etravirine—Eye disorder—Memantine—Alzheimer's disease	0.000858	0.00278	CcSEcCtD
Etravirine—Nervousness—Donepezil—Alzheimer's disease	0.000855	0.00277	CcSEcCtD
Etravirine—Cardiac disorder—Memantine—Alzheimer's disease	0.000852	0.00276	CcSEcCtD
Etravirine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00085	0.00275	CcSEcCtD
Etravirine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00084	0.00272	CcSEcCtD
Etravirine—Insomnia—Galantamine—Alzheimer's disease	0.000839	0.00272	CcSEcCtD
Etravirine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000834	0.0027	CcSEcCtD
Etravirine—Angiopathy—Memantine—Alzheimer's disease	0.000833	0.0027	CcSEcCtD
Etravirine—Paraesthesia—Galantamine—Alzheimer's disease	0.000833	0.0027	CcSEcCtD
Etravirine—Vision blurred—Donepezil—Alzheimer's disease	0.00083	0.00269	CcSEcCtD
Etravirine—Immune system disorder—Memantine—Alzheimer's disease	0.00083	0.00269	CcSEcCtD
Etravirine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000828	0.00268	CcSEcCtD
Etravirine—Tremor—Donepezil—Alzheimer's disease	0.000825	0.00268	CcSEcCtD
Etravirine—Somnolence—Galantamine—Alzheimer's disease	0.000824	0.00267	CcSEcCtD
Etravirine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000817	0.00265	CcSEcCtD
Etravirine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000815	0.00264	CcSEcCtD
Etravirine—Anaemia—Donepezil—Alzheimer's disease	0.000814	0.00264	CcSEcCtD
Etravirine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00081	0.00263	CcSEcCtD
Etravirine—Decreased appetite—Galantamine—Alzheimer's disease	0.000806	0.00261	CcSEcCtD
Etravirine—Mental disorder—Memantine—Alzheimer's disease	0.000805	0.00261	CcSEcCtD
Etravirine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000801	0.0026	CcSEcCtD
Etravirine—Malnutrition—Memantine—Alzheimer's disease	0.000799	0.00259	CcSEcCtD
Etravirine—Fatigue—Galantamine—Alzheimer's disease	0.000799	0.00259	CcSEcCtD
Etravirine—Malaise—Donepezil—Alzheimer's disease	0.000794	0.00258	CcSEcCtD
Etravirine—Constipation—Galantamine—Alzheimer's disease	0.000793	0.00257	CcSEcCtD
Etravirine—Vertigo—Donepezil—Alzheimer's disease	0.000791	0.00257	CcSEcCtD
Etravirine—Syncope—Donepezil—Alzheimer's disease	0.00079	0.00256	CcSEcCtD
Etravirine—Flatulence—Memantine—Alzheimer's disease	0.000788	0.00255	CcSEcCtD
Etravirine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000787	0.00255	CcSEcCtD
Etravirine—Tension—Memantine—Alzheimer's disease	0.000785	0.00254	CcSEcCtD
Etravirine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000782	0.00254	CcSEcCtD
Etravirine—Nervousness—Memantine—Alzheimer's disease	0.000777	0.00252	CcSEcCtD
Etravirine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000774	0.00251	CcSEcCtD
Etravirine—Flatulence—Rivastigmine—Alzheimer's disease	0.000771	0.0025	CcSEcCtD
Etravirine—Tension—Rivastigmine—Alzheimer's disease	0.000768	0.00249	CcSEcCtD
Etravirine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000764	0.00248	CcSEcCtD
Etravirine—Convulsion—Donepezil—Alzheimer's disease	0.000763	0.00247	CcSEcCtD
Etravirine—Hypertension—Donepezil—Alzheimer's disease	0.00076	0.00247	CcSEcCtD
Etravirine—Nervousness—Rivastigmine—Alzheimer's disease	0.00076	0.00246	CcSEcCtD
Etravirine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000758	0.00246	CcSEcCtD
Etravirine—Vision blurred—Memantine—Alzheimer's disease	0.000753	0.00244	CcSEcCtD
Etravirine—Tremor—Memantine—Alzheimer's disease	0.000749	0.00243	CcSEcCtD
Etravirine—Anxiety—Donepezil—Alzheimer's disease	0.000747	0.00242	CcSEcCtD
Etravirine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000742	0.00241	CcSEcCtD
Etravirine—Discomfort—Donepezil—Alzheimer's disease	0.000741	0.0024	CcSEcCtD
Etravirine—Anaemia—Memantine—Alzheimer's disease	0.000739	0.0024	CcSEcCtD
Etravirine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000737	0.00239	CcSEcCtD
Etravirine—Dry mouth—Donepezil—Alzheimer's disease	0.000733	0.00238	CcSEcCtD
Etravirine—Abdominal pain—Galantamine—Alzheimer's disease	0.000733	0.00238	CcSEcCtD
Etravirine—Body temperature increased—Galantamine—Alzheimer's disease	0.000733	0.00238	CcSEcCtD
Etravirine—Tremor—Rivastigmine—Alzheimer's disease	0.000733	0.00238	CcSEcCtD
Etravirine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000726	0.00235	CcSEcCtD
Etravirine—Confusional state—Donepezil—Alzheimer's disease	0.000725	0.00235	CcSEcCtD
Etravirine—Anaemia—Rivastigmine—Alzheimer's disease	0.000723	0.00234	CcSEcCtD
Etravirine—Malaise—Memantine—Alzheimer's disease	0.000721	0.00234	CcSEcCtD
Etravirine—Vertigo—Memantine—Alzheimer's disease	0.000718	0.00233	CcSEcCtD
Etravirine—Syncope—Memantine—Alzheimer's disease	0.000717	0.00233	CcSEcCtD
Etravirine—Infection—Donepezil—Alzheimer's disease	0.000714	0.00232	CcSEcCtD
Etravirine—Shock—Donepezil—Alzheimer's disease	0.000707	0.00229	CcSEcCtD
Etravirine—Malaise—Rivastigmine—Alzheimer's disease	0.000705	0.00229	CcSEcCtD
Etravirine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000705	0.00229	CcSEcCtD
Etravirine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000704	0.00228	CcSEcCtD
Etravirine—Vertigo—Rivastigmine—Alzheimer's disease	0.000703	0.00228	CcSEcCtD
Etravirine—Loss of consciousness—Memantine—Alzheimer's disease	0.000703	0.00228	CcSEcCtD
Etravirine—Syncope—Rivastigmine—Alzheimer's disease	0.000701	0.00227	CcSEcCtD
Etravirine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000695	0.00225	CcSEcCtD
Etravirine—Convulsion—Memantine—Alzheimer's disease	0.000693	0.00225	CcSEcCtD
Etravirine—Hypertension—Memantine—Alzheimer's disease	0.00069	0.00224	CcSEcCtD
Etravirine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000687	0.00223	CcSEcCtD
Etravirine—Anorexia—Donepezil—Alzheimer's disease	0.000685	0.00222	CcSEcCtD
Etravirine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000683	0.00222	CcSEcCtD
Etravirine—Anxiety—Memantine—Alzheimer's disease	0.000678	0.0022	CcSEcCtD
Etravirine—Convulsion—Rivastigmine—Alzheimer's disease	0.000678	0.0022	CcSEcCtD
Etravirine—Hypertension—Rivastigmine—Alzheimer's disease	0.000675	0.00219	CcSEcCtD
Etravirine—Discomfort—Memantine—Alzheimer's disease	0.000672	0.00218	CcSEcCtD
Etravirine—Dry mouth—Memantine—Alzheimer's disease	0.000666	0.00216	CcSEcCtD
Etravirine—Asthenia—Galantamine—Alzheimer's disease	0.000665	0.00216	CcSEcCtD
Etravirine—Anxiety—Rivastigmine—Alzheimer's disease	0.000664	0.00215	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000661	0.00214	CcSEcCtD
Etravirine—Confusional state—Memantine—Alzheimer's disease	0.000658	0.00213	CcSEcCtD
Etravirine—Discomfort—Rivastigmine—Alzheimer's disease	0.000658	0.00213	CcSEcCtD
Etravirine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000651	0.00211	CcSEcCtD
Etravirine—Insomnia—Donepezil—Alzheimer's disease	0.00065	0.00211	CcSEcCtD
Etravirine—Infection—Memantine—Alzheimer's disease	0.000648	0.0021	CcSEcCtD
Etravirine—Paraesthesia—Donepezil—Alzheimer's disease	0.000645	0.00209	CcSEcCtD
Etravirine—Confusional state—Rivastigmine—Alzheimer's disease	0.000644	0.00209	CcSEcCtD
Etravirine—Shock—Memantine—Alzheimer's disease	0.000642	0.00208	CcSEcCtD
Etravirine—Nervous system disorder—Memantine—Alzheimer's disease	0.00064	0.00208	CcSEcCtD
Etravirine—Somnolence—Donepezil—Alzheimer's disease	0.000639	0.00207	CcSEcCtD
Etravirine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000639	0.00207	CcSEcCtD
Etravirine—Diarrhoea—Galantamine—Alzheimer's disease	0.000634	0.00206	CcSEcCtD
Etravirine—Infection—Rivastigmine—Alzheimer's disease	0.000634	0.00206	CcSEcCtD
Etravirine—Skin disorder—Memantine—Alzheimer's disease	0.000634	0.00206	CcSEcCtD
Etravirine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000631	0.00205	CcSEcCtD
Etravirine—Shock—Rivastigmine—Alzheimer's disease	0.000628	0.00204	CcSEcCtD
Etravirine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000626	0.00203	CcSEcCtD
Etravirine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000625	0.00203	CcSEcCtD
Etravirine—Decreased appetite—Donepezil—Alzheimer's disease	0.000625	0.00203	CcSEcCtD
Etravirine—Anorexia—Memantine—Alzheimer's disease	0.000622	0.00202	CcSEcCtD
Etravirine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00062	0.00201	CcSEcCtD
Etravirine—Skin disorder—Rivastigmine—Alzheimer's disease	0.00062	0.00201	CcSEcCtD
Etravirine—Fatigue—Donepezil—Alzheimer's disease	0.00062	0.00201	CcSEcCtD
Etravirine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000617	0.002	CcSEcCtD
Etravirine—Pain—Donepezil—Alzheimer's disease	0.000615	0.00199	CcSEcCtD
Etravirine—Constipation—Donepezil—Alzheimer's disease	0.000615	0.00199	CcSEcCtD
Etravirine—Dizziness—Galantamine—Alzheimer's disease	0.000613	0.00199	CcSEcCtD
Etravirine—Anorexia—Rivastigmine—Alzheimer's disease	0.000608	0.00197	CcSEcCtD
Etravirine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000592	0.00192	CcSEcCtD
Etravirine—Insomnia—Memantine—Alzheimer's disease	0.00059	0.00191	CcSEcCtD
Etravirine—Vomiting—Galantamine—Alzheimer's disease	0.00059	0.00191	CcSEcCtD
Etravirine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000588	0.00191	CcSEcCtD
Etravirine—Paraesthesia—Memantine—Alzheimer's disease	0.000586	0.0019	CcSEcCtD
Etravirine—Rash—Galantamine—Alzheimer's disease	0.000585	0.0019	CcSEcCtD
Etravirine—Dermatitis—Galantamine—Alzheimer's disease	0.000584	0.00189	CcSEcCtD
Etravirine—Headache—Galantamine—Alzheimer's disease	0.000581	0.00188	CcSEcCtD
Etravirine—Somnolence—Memantine—Alzheimer's disease	0.00058	0.00188	CcSEcCtD
Etravirine—Insomnia—Rivastigmine—Alzheimer's disease	0.000577	0.00187	CcSEcCtD
Etravirine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000573	0.00186	CcSEcCtD
Etravirine—Abdominal pain—Donepezil—Alzheimer's disease	0.000568	0.00184	CcSEcCtD
Etravirine—Body temperature increased—Donepezil—Alzheimer's disease	0.000568	0.00184	CcSEcCtD
Etravirine—Somnolence—Rivastigmine—Alzheimer's disease	0.000567	0.00184	CcSEcCtD
Etravirine—Decreased appetite—Memantine—Alzheimer's disease	0.000567	0.00184	CcSEcCtD
Etravirine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000563	0.00183	CcSEcCtD
Etravirine—Fatigue—Memantine—Alzheimer's disease	0.000563	0.00182	CcSEcCtD
Etravirine—Constipation—Memantine—Alzheimer's disease	0.000558	0.00181	CcSEcCtD
Etravirine—Pain—Memantine—Alzheimer's disease	0.000558	0.00181	CcSEcCtD
Etravirine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000555	0.0018	CcSEcCtD
Etravirine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000551	0.00179	CcSEcCtD
Etravirine—Nausea—Galantamine—Alzheimer's disease	0.000551	0.00179	CcSEcCtD
Etravirine—Fatigue—Rivastigmine—Alzheimer's disease	0.00055	0.00178	CcSEcCtD
Etravirine—Constipation—Rivastigmine—Alzheimer's disease	0.000546	0.00177	CcSEcCtD
Etravirine—Pain—Rivastigmine—Alzheimer's disease	0.000546	0.00177	CcSEcCtD
Etravirine—Feeling abnormal—Memantine—Alzheimer's disease	0.000538	0.00174	CcSEcCtD
Etravirine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000534	0.00173	CcSEcCtD
Etravirine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000529	0.00172	CcSEcCtD
Etravirine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000526	0.00171	CcSEcCtD
Etravirine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000522	0.00169	CcSEcCtD
Etravirine—Abdominal pain—Memantine—Alzheimer's disease	0.000516	0.00167	CcSEcCtD
Etravirine—Body temperature increased—Memantine—Alzheimer's disease	0.000516	0.00167	CcSEcCtD
Etravirine—Asthenia—Donepezil—Alzheimer's disease	0.000516	0.00167	CcSEcCtD
Etravirine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000505	0.00164	CcSEcCtD
Etravirine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000505	0.00164	CcSEcCtD
Etravirine—Diarrhoea—Donepezil—Alzheimer's disease	0.000492	0.00159	CcSEcCtD
Etravirine—Hypersensitivity—Memantine—Alzheimer's disease	0.000481	0.00156	CcSEcCtD
Etravirine—Dizziness—Donepezil—Alzheimer's disease	0.000475	0.00154	CcSEcCtD
Etravirine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00047	0.00153	CcSEcCtD
Etravirine—Asthenia—Memantine—Alzheimer's disease	0.000468	0.00152	CcSEcCtD
Etravirine—Asthenia—Rivastigmine—Alzheimer's disease	0.000458	0.00149	CcSEcCtD
Etravirine—Vomiting—Donepezil—Alzheimer's disease	0.000457	0.00148	CcSEcCtD
Etravirine—Rash—Donepezil—Alzheimer's disease	0.000453	0.00147	CcSEcCtD
Etravirine—Dermatitis—Donepezil—Alzheimer's disease	0.000453	0.00147	CcSEcCtD
Etravirine—Headache—Donepezil—Alzheimer's disease	0.00045	0.00146	CcSEcCtD
Etravirine—Diarrhoea—Memantine—Alzheimer's disease	0.000446	0.00145	CcSEcCtD
Etravirine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000437	0.00142	CcSEcCtD
Etravirine—Dizziness—Memantine—Alzheimer's disease	0.000431	0.0014	CcSEcCtD
Etravirine—Nausea—Donepezil—Alzheimer's disease	0.000427	0.00138	CcSEcCtD
Etravirine—Dizziness—Rivastigmine—Alzheimer's disease	0.000422	0.00137	CcSEcCtD
Etravirine—Vomiting—Memantine—Alzheimer's disease	0.000415	0.00135	CcSEcCtD
Etravirine—Rash—Memantine—Alzheimer's disease	0.000411	0.00133	CcSEcCtD
Etravirine—Dermatitis—Memantine—Alzheimer's disease	0.000411	0.00133	CcSEcCtD
Etravirine—Headache—Memantine—Alzheimer's disease	0.000409	0.00133	CcSEcCtD
Etravirine—Vomiting—Rivastigmine—Alzheimer's disease	0.000406	0.00132	CcSEcCtD
Etravirine—Rash—Rivastigmine—Alzheimer's disease	0.000402	0.00131	CcSEcCtD
Etravirine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000402	0.0013	CcSEcCtD
Etravirine—Headache—Rivastigmine—Alzheimer's disease	0.0004	0.0013	CcSEcCtD
Etravirine—Nausea—Memantine—Alzheimer's disease	0.000388	0.00126	CcSEcCtD
Etravirine—Nausea—Rivastigmine—Alzheimer's disease	0.000379	0.00123	CcSEcCtD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000162	0.00279	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—A2M—Alzheimer's disease	0.000159	0.00275	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.000153	0.00265	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00015	0.00258	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000142	0.00245	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ACHE—Alzheimer's disease	0.000139	0.00239	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000137	0.00237	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—INPP5D—Alzheimer's disease	0.000137	0.00237	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000135	0.00234	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000133	0.0023	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000133	0.00229	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—MAOB—Alzheimer's disease	0.000132	0.00228	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000131	0.00227	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ENO1—Alzheimer's disease	0.00013	0.00224	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS1—Alzheimer's disease	0.00013	0.00224	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000127	0.0022	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2D6—Alzheimer's disease	0.000127	0.0022	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL1A—Alzheimer's disease	0.000124	0.00215	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—BCHE—Alzheimer's disease	0.000121	0.00209	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.00012	0.00208	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000118	0.00204	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.000118	0.00203	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000116	0.00201	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000116	0.00201	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PLCB1—Alzheimer's disease	0.000114	0.00197	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000113	0.00196	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000112	0.00193	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000111	0.00192	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ABCA1—Alzheimer's disease	0.00011	0.00191	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.00011	0.00189	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000108	0.00186	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000107	0.00185	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000104	0.0018	CbGpPWpGaD
Etravirine—CYP2C19—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000103	0.00178	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.000101	0.00175	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	0.0001	0.00173	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	9.82e-05	0.0017	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	9.76e-05	0.00169	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	9.68e-05	0.00167	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	9.59e-05	0.00166	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PPARGC1A—Alzheimer's disease	9.52e-05	0.00164	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—HMOX1—Alzheimer's disease	9.47e-05	0.00164	CbGpPWpGaD
Etravirine—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	9.4e-05	0.00162	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	9.21e-05	0.00159	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	9.13e-05	0.00158	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	8.95e-05	0.00155	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.83e-05	0.00153	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—LPL—Alzheimer's disease	8.66e-05	0.0015	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	8.5e-05	0.00147	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	8.5e-05	0.00147	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	8.4e-05	0.00145	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	8.35e-05	0.00144	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	8.2e-05	0.00142	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	7.94e-05	0.00137	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—MTHFR—Alzheimer's disease	7.8e-05	0.00135	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	7.75e-05	0.00134	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CALM1—Alzheimer's disease	7.29e-05	0.00126	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—APOE—Alzheimer's disease	7.26e-05	0.00125	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CAV1—Alzheimer's disease	7.2e-05	0.00124	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	6.97e-05	0.0012	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	6.49e-05	0.00112	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	6.48e-05	0.00112	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	6.4e-05	0.00111	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	6.35e-05	0.0011	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PPARG—Alzheimer's disease	6.33e-05	0.00109	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—INS—Alzheimer's disease	6.2e-05	0.00107	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	6.02e-05	0.00104	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	5.95e-05	0.00103	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	5.9e-05	0.00102	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.82e-05	0.00101	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	5.67e-05	0.00098	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—DHCR24—Alzheimer's disease	5.54e-05	0.000957	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	5.5e-05	0.00095	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—NOS3—Alzheimer's disease	5.44e-05	0.00094	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.29e-05	0.000914	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	5.17e-05	0.000894	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	5.04e-05	0.000872	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS2—Alzheimer's disease	4.98e-05	0.00086	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA4—Alzheimer's disease	4.82e-05	0.000834	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.82e-05	0.000833	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.8e-05	0.000829	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.72e-05	0.000815	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	4.71e-05	0.000814	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA4—Alzheimer's disease	4.71e-05	0.000814	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	4.54e-05	0.000784	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	4.43e-05	0.000765	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA4—Alzheimer's disease	4.4e-05	0.00076	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	4.38e-05	0.000756	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	4.32e-05	0.000746	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	4.3e-05	0.000743	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.3e-05	0.000743	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	4.2e-05	0.000725	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.15e-05	0.000717	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	4.14e-05	0.000715	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLD3—Alzheimer's disease	4.1e-05	0.000709	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.1e-05	0.000709	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.06e-05	0.000701	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	4.05e-05	0.0007	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLD3—Alzheimer's disease	4e-05	0.000692	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	3.93e-05	0.00068	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	3.92e-05	0.000677	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.84e-05	0.000664	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	3.84e-05	0.000663	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	3.79e-05	0.000654	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLD3—Alzheimer's disease	3.74e-05	0.000646	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.74e-05	0.000646	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.72e-05	0.000643	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.7e-05	0.000639	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	3.7e-05	0.000638	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ND1—Alzheimer's disease	3.66e-05	0.000632	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.62e-05	0.000626	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	3.59e-05	0.00062	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.57e-05	0.000617	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ND1—Alzheimer's disease	3.57e-05	0.000617	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.51e-05	0.000606	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	3.45e-05	0.000596	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.44e-05	0.000595	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.41e-05	0.00059	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ND1—Alzheimer's disease	3.33e-05	0.000576	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.27e-05	0.000565	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.26e-05	0.000563	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.2e-05	0.000552	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.98e-05	0.000515	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.94e-05	0.000508	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.9e-05	0.000501	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.82e-05	0.000487	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.73e-05	0.000471	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.71e-05	0.000469	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.6e-05	0.00045	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.59e-05	0.000447	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.57e-05	0.000444	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.56e-05	0.000443	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—AKT1—Alzheimer's disease	2.5e-05	0.000432	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.49e-05	0.00043	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.47e-05	0.000426	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.37e-05	0.000409	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CHAT—Alzheimer's disease	2.36e-05	0.000407	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TPI1—Alzheimer's disease	2.36e-05	0.000407	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.34e-05	0.000404	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.32e-05	0.000402	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.3e-05	0.000397	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.3e-05	0.000397	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.28e-05	0.000393	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	2.26e-05	0.00039	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MAOB—Alzheimer's disease	2.2e-05	0.000381	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.2e-05	0.00038	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	2.17e-05	0.000376	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.15e-05	0.000371	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	2.15e-05	0.000371	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	2.15e-05	0.000371	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.13e-05	0.000368	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.12e-05	0.000367	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—A2M—Alzheimer's disease	2.1e-05	0.000363	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	2.06e-05	0.000356	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—A2M—Alzheimer's disease	2.05e-05	0.000354	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.05e-05	0.000354	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.98e-05	0.000343	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.96e-05	0.000339	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.94e-05	0.000336	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.91e-05	0.000331	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.87e-05	0.000324	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.83e-05	0.000316	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.81e-05	0.000312	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.78e-05	0.000308	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.76e-05	0.000305	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.73e-05	0.000299	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.71e-05	0.000296	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.71e-05	0.000296	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.71e-05	0.000295	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.68e-05	0.00029	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.67e-05	0.000289	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.67e-05	0.000289	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	1.67e-05	0.000288	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	1.65e-05	0.000285	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.64e-05	0.000283	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.59e-05	0.000275	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	1.56e-05	0.00027	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	1.56e-05	0.00027	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.55e-05	0.000268	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	1.53e-05	0.000264	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.5e-05	0.000259	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.47e-05	0.000255	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.47e-05	0.000253	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.46e-05	0.000252	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	1.45e-05	0.000251	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.42e-05	0.000245	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.42e-05	0.000245	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.42e-05	0.000245	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	1.37e-05	0.000237	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.36e-05	0.000235	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.34e-05	0.000232	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	1.33e-05	0.000229	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.31e-05	0.000226	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.26e-05	0.000218	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	1.25e-05	0.000217	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	1.25e-05	0.000216	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.22e-05	0.000212	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.22e-05	0.000211	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	1.14e-05	0.000198	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LPL—Alzheimer's disease	1.14e-05	0.000197	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	1.14e-05	0.000197	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LPL—Alzheimer's disease	1.11e-05	0.000193	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.1e-05	0.00019	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.09e-05	0.000188	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.04e-05	0.00018	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.03e-05	0.000178	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.03e-05	0.000178	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.03e-05	0.000178	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.01e-05	0.000174	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1e-05	0.000173	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	9.61e-06	0.000166	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APOE—Alzheimer's disease	9.57e-06	0.000165	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	9.57e-06	0.000165	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	9.49e-06	0.000164	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CALM1—Alzheimer's disease	9.38e-06	0.000162	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	9.38e-06	0.000162	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APOE—Alzheimer's disease	9.35e-06	0.000161	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAV1—Alzheimer's disease	9.26e-06	0.00016	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	9.03e-06	0.000156	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	8.76e-06	0.000151	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	8.75e-06	0.000151	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APOE—Alzheimer's disease	8.73e-06	0.000151	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	8.65e-06	0.000149	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	8.34e-06	0.000144	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—INS—Alzheimer's disease	8.18e-06	0.000141	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARG—Alzheimer's disease	8.14e-06	0.000141	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—INS—Alzheimer's disease	7.98e-06	0.000138	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	7.6e-06	0.000131	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	7.54e-06	0.00013	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	7.51e-06	0.00013	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—INS—Alzheimer's disease	7.46e-06	0.000129	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	7.17e-06	0.000124	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—Alzheimer's disease	7e-06	0.000121	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LPL—Alzheimer's disease	6.87e-06	0.000119	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	6.56e-06	0.000113	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	6.54e-06	0.000113	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	6.4e-06	0.000111	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	6.18e-06	0.000107	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	5.98e-06	0.000103	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	5.78e-06	9.98e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APOE—Alzheimer's disease	5.76e-06	9.95e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	5.7e-06	9.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	5.02e-06	8.66e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—INS—Alzheimer's disease	4.92e-06	8.5e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	4.31e-06	7.45e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.95e-06	6.82e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	3.3e-06	5.7e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—Alzheimer's disease	3.22e-06	5.56e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	3.01e-06	5.19e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.98e-06	3.43e-05	CbGpPWpGaD
